Display options
Share it on

Front Genet. 2020 Jun 08;11:613. doi: 10.3389/fgene.2020.00613. eCollection 2020.

Lack of Association Between Genetic Variants at .

Frontiers in genetics

Esteban A Lopera Maya, Adriaan van der Graaf, Pauline Lanting, Marije van der Geest, Jingyuan Fu, Morris Swertz, Lude Franke, Cisca Wijmenga, Patrick Deelen, Alexandra Zhernakova, Serena Sanna,

Affiliations

  1. Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  2. Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  3. Department of Genetics, University Medical Centre Utrecht, Utrecht, Netherlands.
  4. Institute for Genetics and Biomedical Research (IRGB), Consiglio Nazionale delle Ricerche (CNR), Monserrato, Italy.

PMID: 32582302 PMCID: PMC7295011 DOI: 10.3389/fgene.2020.00613

Abstract

Coronavirus disease 2019 (COVID-19) shows a wide variation in expression and severity of symptoms, from very mild or no symptoms, to flu-like symptoms, and in more severe cases, to pneumonia, acute respiratory distress syndrome, and even death. Large differences in outcome have also been observed between males and females. The causes for this variability are likely to be multifactorial, and to include genetics. The SARS-CoV-2 virus responsible for the infection depends on two human genes: the human receptor angiotensin converting enzyme 2 (

Copyright © 2020 Lopera Maya, van der Graaf, Lanting, van der Geest, Fu, Swertz, Franke, Wijmenga, Deelen, Zhernakova, Sanna and Lifelines Cohort Study.

Keywords: ACE2; ARBs (angiotensin II receptor blockers); COVID-19; NSAIDs (non-steroidal anti-inflammatory drugs); PheWAS; SARS-CoV-2; TMPRSS2

References

  1. Bioinformatics. 2017 Aug 1;33(15):2251-2257 - PubMed
  2. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1620-5 - PubMed
  3. Lancet. 2020 Mar 28;395(10229):1054-1062 - PubMed
  4. PLoS Genet. 2015 Oct 01;11(10):e1005378 - PubMed
  5. N Engl J Med. 2020 Jun 18;382(25):e102 - PubMed
  6. Science. 2016 Apr 29;352(6285):565-9 - PubMed
  7. Bioinformatics. 2019 Mar 15;35(6):1076-1078 - PubMed
  8. Lancet. 2020 Feb 15;395(10223):507-513 - PubMed
  9. Cell. 2020 Apr 16;181(2):271-280.e8 - PubMed
  10. Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11869-74 - PubMed
  11. Clin Epidemiol. 2018 Aug 16;10:981-989 - PubMed
  12. Nature. 2018 Jun;558(7708):73-79 - PubMed
  13. BMJ. 2020 Mar 27;368:m1185 - PubMed
  14. Nat Genet. 2018 Nov;50(11):1524-1532 - PubMed
  15. BMJ. 2020 Feb 19;368:m606 - PubMed
  16. Ecancermedicalscience. 2020 Mar 30;14:1023 - PubMed
  17. Eur Heart J. 2020 May 14;41(19):1801-1803 - PubMed
  18. Nat Genet. 2018 Sep;50(9):1335-1341 - PubMed
  19. Pharmacogenet Genomics. 2011 Sep;21(9):531-8 - PubMed
  20. JAMA. 2020 Feb 24;: - PubMed
  21. Eur J Hum Genet. 2020 Jun;28(6):715-718 - PubMed
  22. Int J Clin Pract. 2007 Dec;61(12):2093-102 - PubMed
  23. Lancet. 2020 Feb 15;395(10223):497-506 - PubMed
  24. Nature. 2015 Oct 1;526(7571):68-74 - PubMed
  25. Science. 2020 Mar 27;367(6485):1444-1448 - PubMed
  26. Int J Epidemiol. 2015 Aug;44(4):1172-80 - PubMed
  27. Am J Hypertens. 2004 Mar;17(3):277-80 - PubMed
  28. BMJ Open. 2015 Aug 28;5(8):e006772 - PubMed
  29. Nat Genet. 2015 Jul;47(7):822-826 - PubMed
  30. N Engl J Med. 2020 Jun 18;382(25):2431-2440 - PubMed
  31. Nat Genet. 2007 Oct;39(10):1197-9 - PubMed
  32. Eur Respir J. 2020 May 14;55(5): - PubMed
  33. Bioinformatics. 2010 Sep 15;26(18):2336-7 - PubMed

Publication Types